PVOTF - Pivot Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue1/31/20181/31/20171/31/20161/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development70.30470.30470.30470.304
Selling General and Administrative852.415,829.08610,307.25764.145
Non Recurring----
Others----
Total Operating Expenses947.7895,829.08610,307.57964.554
Operating Income or Loss-947.789-5,829.086-10,307.579-64.554
Income from Continuing Operations
Total Other Income/Expenses Net826.607-449.1210.514-1,064.45
Earnings Before Interest and Taxes-947.789-5,829.086-10,307.579-64.554
Interest Expense-132.777-81.445-81.445-73.611
Income Before Tax-121.182-6,278.207-10,307.065-1,129.004
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-121.182-6,278.207-10,307.065-1,129.004
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-121.182-6,278.207-10,307.065-1,129.004
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-121.182-6,278.207-10,307.065-1,129.004